GrandOmics Biosciences
PrivateLast Round
Series B
Jul 2, 2018
Total Funding Raised
$29.4M
Company Overview
GrandOmics Biosciences operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in July 2018.
GrandOmics Biosciences is a biotechnology company that provides third-generation sequencing services, bioinformatics analysis, and genomic solutions for human, animal, plant, and microbial research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GrandOmics Biosciences Comparables
Compare GrandOmics Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuhan Frasergen Bioinformatics Co., Ltd. | 87% | |
| Wuhan Benagen Technology Co., Ltd. | 86% | |
| Chigene (Beijing) Translational Medical Research Center Co., Ltd. | 83% |
For institutional investors. Book with your work email.
GrandOmics Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 2, 2018 | ||||
| Series A | Dec 5, 2016 | ||||
| Angel | Dec 1, 2015 |
For institutional investors. Book with your work email.
GrandOmics Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zero2IPO Venture Capital | Series A |
| Marathon Venture Partners | Series B |
| MPC | Series B, Series A |
| SAIF Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2018
$15M round led by Marathon Venture Partners.
For institutional investors. Book with your work email.
GrandOmics Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GrandOmics Biosciences's valuation, stock price, and market status.
Is GrandOmics Biosciences a public or private company?
GrandOmics Biosciences is a private company.
What is the current stock price of GrandOmics Biosciences?
GrandOmics Biosciences is a private company, so its shares have no public market price. Caplight tracks GrandOmics Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GrandOmics Biosciences worth (valuation)?
Valuation information for GrandOmics Biosciences is not publicly available.
Can I buy GrandOmics Biosciences stock?
GrandOmics Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GrandOmics Biosciences's last funding round?
GrandOmics Biosciences's most recent funding round was Series B on July 2, 2018.
Who are the main investors in GrandOmics Biosciences?
Key investors in GrandOmics Biosciences include Marathon Venture Partners, MPC, SAIF Partners.
Will GrandOmics Biosciences IPO soon?
No public IPO plans have been announced for GrandOmics Biosciences.
How can I track GrandOmics Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in GrandOmics Biosciences's shares on secondary markets.